Matrix-Associated Stem Cell Transplantation (MAST) in Chondral Defects of the 1st Metatarsophalangeal Joint is Safe and Effective – 2-Year-Follow-up…

Publication date: Available online 27 May 2016 Source: Foot and Ankle Surgery Author(s): Martinus Richter, Stefan Zech, Stefan Meissner The aim of the study was to assess the 2-year-follow-up of matrix-associated stem cell transplantation (MAST) in chondral defects of the 1st metatarsophalangeal joint (MTPJ). In a prospective consecutive non-controlled clinical follow-up study, 20 patients with 25 chondral defect at the 1st MTPJ that were treated with MAST from October 1st, 2011 to March, 30th, 2013 were analysed. The size and location of the chondral defects range of motion (ROM), and the Visual-Analogue-Scale Foot and Ankle (VAS FA) before treatment and at follow-up were registered

Publication date: Available online 27 May 2016 Source: Foot and Ankle Surgery Author(s): Martinus Richter, Stefan Zech, Stefan Meissner The aim of the study was to assess the 2-year-follow-up of matrix-associated stem cell transplantation (MAST) in chondral defects of the 1st metatarsophalangeal joint (MTPJ). In a prospective consecutive non-controlled clinical follow-up study, 20 patients with 25 chondral defect at the 1st MTPJ that were treated with MAST from October 1st, 2011 to March, 30th, 2013 were analysed. The size and location of the chondral defects range of motion (ROM), and the Visual-Analogue-Scale Foot and Ankle (VAS FA) before treatment and at follow-up were registered

Taken from:
Matrix-Associated Stem Cell Transplantation (MAST) in Chondral Defects of the 1st Metatarsophalangeal Joint is Safe and Effective – 2-Year-Follow-up…